Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug
18 sept. 2024 08h00 HE
|
Certara
Certara shared the results from its collaboration with Ichnos Glenmark Innovation (IGI) on the first-in-human dose prediction and selection for ISB 2001.
Certara to Participate in Upcoming Investor Conferences
21 août 2024 16h15 HE
|
Certara
RADNOR, Pa., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the...
Certara Launches Phoenix™ Version 8.5 Drug Development Software
15 août 2024 16h15 HE
|
Certara
Certara today announced the launch of Phoenix™ version 8.5 software, the pharmaceutical industry's gold standard in PK/PD modeling and simulation.
Certara Reports Second Quarter 2024 Financial Results
06 août 2024 16h15 HE
|
Certara
RADNOR, Pa., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the second quarter of fiscal...
Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio
09 juil. 2024 16h45 HE
|
Certara
Certara has signed a definitive agreement to acquire Chemaxon, a leading provider of cheminformatics software.
Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024
02 juil. 2024 16h15 HE
|
Certara
RADNOR, Pa., July 02, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the second...
Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software
17 juin 2024 08h00 HE
|
Certara
Certara today unveiled its next-generation CoAuthor regulatory writing software. CoAuthor is an advanced writing platform designed for medical writers.
Certara to Participate in the Jefferies Global Healthcare Conference
29 mai 2024 16h15 HE
|
Certara
RADNOR, Pa., May 29, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the Jefferies Global...
Certara Appoints New Chief Human Resources Officer & General Counsel
21 mai 2024 08h00 HE
|
Certara
Certara has appointed Rona Anhalt as Chief Human Resources Officer and Daniel Corcoran as General Counsel.
Certara Reports First Quarter 2024 Financial Results
07 mai 2024 16h15 HE
|
Certara
PRINCETON, N.J., May 07, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the first quarter of fiscal year 2024. ...